| dc.creator |
DEMİRKAZIK, AHMET |
|
| dc.creator |
Turhal, Nazim Serdar |
|
| dc.creator |
Bozcuk, Hakan |
|
| dc.creator |
COŞKUN, HASAN ŞENOL |
|
| dc.creator |
ENGİN, HÜSEYİN |
|
| dc.creator |
ARTAÇ, MEHMET |
|
| dc.creator |
Korkmaz, Levent |
|
| dc.creator |
Dede, Isa |
|
| dc.creator |
Oksuzoglu, Berna |
|
| dc.creator |
PAYDAŞ, SEMRA |
|
| dc.creator |
Kocer, Murat |
|
| dc.date |
2016-07-31T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T11:26:33Z |
|
| dc.date.available |
2020-10-06T11:26:33Z |
|
| dc.identifier |
e1497000-5593-4195-a743-280f8840a0fc |
|
| dc.identifier |
10.1016/j.clgc.2016.04.021 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/e1497000-5593-4195-a743-280f8840a0fc/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/74287 |
|
| dc.description |
Survival outcomes of interferon-alfa and tyrosine kinase inhibitors for 104 cases of metastatic renal cell carcinoma were included in this study. First-line interferon-alfa treatment before tyrosine kinase inhibitors had an additive survival affect. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study |
|
| dc.type |
info:eu-repo/semantics/article |
|